Tuberculous meningitis in HIV-infected and non-infected patients: Comparison of cerebrospinal fluid findings

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 2, 2009, Pages 269-271

  Cecchini, Diego ^a,b   Ambrosioni, J ^a   Brezzo, C ^a   Corti, M ^a   Rybko, A ^a   Perez, M ^a   Poggi, S ^a   Ambroggi, M ^a  

^a HOSPITAL F J MUÑIZ   (Argentina)

^b NONE   (Argentina)

Author keywords

Cerebrospinal fluid; HIV; Multidrug resistance; Pleocytosis; Tuberculous meningitis

Indexed keywords

ETHAMBUTOL; GLUCOSE; ISONIAZID; KANAMYCIN; PROTEIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CELL COUNT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID CYTOLOGY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG COMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; PLEOCYTOSIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RETROSPECTIVE STUDY; TUBERCULOUS MENINGITIS;

ADULT; ANTITUBERCULAR AGENTS; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FEMALE; GLUCOSE; HIV INFECTIONS; HOSPITAL MORTALITY; HUMANS; ISONIAZID; LEUKOCYTE COUNT; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, MENINGEAL; YOUNG ADULT;

EID: 59549107155     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Thwaites G, Duc Bang N, Huy Dung N, et al. The influence of HIV infection on clinical presentation, response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005; 192: 2134-2141.
2. Schutte C. Clinical, cerebrospinal fluid and pathological findings and outcomes in HIV-positive and HIV-negative patients with tuberculous meningitis. Infection 2001; 29: 213-217.
3. Laguna F, Adrados M, Ortega A, Gonzalez-Lahoz J M. Tuberculous meningitis with acellular cerebrospinal fluid in AIDS patients. AIDS 1992; 6: 1165-1167.
4. Thwaites G, Lan N, Dung N. Effect of anti-tuberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005; 192: 79-88.
5. Cecchini D, Ambrosioni J, Brezzo C, et al. Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome. AIDS 2007; 21: 373-374.
6. Laszlo A, Rahman M, Raviglione M, Bustreo F, and the WHO/ IUATLD Network of Supranational Reference Laboratories. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int J Tuberc Lung Dis 1997; 1: 231-238.
7. Laszlo A, Gill P, Handzel V, Hodgkin M, Helbecque D. Conventional and radiometric drug susceptibility testing of Mycobacterium tuberculosis complex. J Clin Microbiol 1983; 18: 1335-1339.
8. Topley J, Bamber S, Coovadia H, Corr P. Tuberculous meningitis and co-infection with HIV. Ann Trop Paediatr 1998; 18: 261-266.
9. Patel V, Padayatchi N, Bhigjee A, et al. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa. Clin Infect Dis 2004; 38: 851-856.
10. Ritacco V, Di Lonardo M, Reniero A, et al. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J Infect Dis 1997; 176: 748-751.